JP7573536B2 - 無細胞ｄｎａを単離するための組成物および方法 - Google Patents
無細胞ｄｎａを単離するための組成物および方法 Download PDFInfo
- Publication number
- JP7573536B2 JP7573536B2 JP2021544183A JP2021544183A JP7573536B2 JP 7573536 B2 JP7573536 B2 JP 7573536B2 JP 2021544183 A JP2021544183 A JP 2021544183A JP 2021544183 A JP2021544183 A JP 2021544183A JP 7573536 B2 JP7573536 B2 JP 7573536B2
- Authority
- JP
- Japan
- Prior art keywords
- target regions
- sequence
- epigenetic
- cancer
- cfdna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024104756A JP2024125391A (ja) | 2019-01-31 | 2024-06-28 | 無細胞ｄｎａを単離するための組成物および方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962799637P | 2019-01-31 | 2019-01-31 | |
| US62/799,637 | 2019-01-31 | ||
| PCT/US2020/016120 WO2020160414A1 (en) | 2019-01-31 | 2020-01-31 | Compositions and methods for isolating cell-free dna |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024104756A Division JP2024125391A (ja) | 2019-01-31 | 2024-06-28 | 無細胞ｄｎａを単離するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022519045A JP2022519045A (ja) | 2022-03-18 |
| JP2022519045A5 JP2022519045A5 (https=) | 2023-02-08 |
| JP7573536B2 true JP7573536B2 (ja) | 2024-10-25 |
Family
ID=69740753
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544183A Active JP7573536B2 (ja) | 2019-01-31 | 2020-01-31 | 無細胞ｄｎａを単離するための組成物および方法 |
| JP2024104756A Pending JP2024125391A (ja) | 2019-01-31 | 2024-06-28 | 無細胞ｄｎａを単離するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024104756A Pending JP2024125391A (ja) | 2019-01-31 | 2024-06-28 | 無細胞ｄｎａを単離するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11643693B2 (https=) |
| EP (2) | EP4567131A3 (https=) |
| JP (2) | JP7573536B2 (https=) |
| CN (1) | CN113661249B (https=) |
| AU (2) | AU2020216438A1 (https=) |
| CA (1) | CA3126428A1 (https=) |
| ES (1) | ES3013495T3 (https=) |
| WO (1) | WO2020160414A1 (https=) |
Families Citing this family (85)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020160414A1 (en) * | 2019-01-31 | 2020-08-06 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| EP3976822A1 (en) | 2019-05-31 | 2022-04-06 | Guardant Health, Inc. | Methods and systems for improving patient monitoring after surgery |
| US20210102262A1 (en) * | 2019-09-23 | 2021-04-08 | Grail, Inc. | Systems and methods for diagnosing a disease condition using on-target and off-target sequencing data |
| US11891653B2 (en) | 2019-09-30 | 2024-02-06 | Guardant Health, Inc. | Compositions and methods for analyzing cell-free DNA in methylation partitioning assays |
| JP7842700B2 (ja) | 2020-05-14 | 2026-04-08 | ガーダント ヘルス， インコーポレイテッド | 相同組換え修復欠損の検出 |
| EP4585697A3 (en) * | 2020-07-30 | 2025-08-06 | Guardant Health, Inc. | Methods for isolating cell-free dna |
| EP4205126A1 (en) * | 2020-08-25 | 2023-07-05 | Guardant Health, Inc. | Methods and systems for predicting an origin of a variant |
| AU2021345359A1 (en) | 2020-09-21 | 2023-05-11 | Enumera Molecular, Inc. | Compositions and methods for isolation of cell-free dna |
| EP4222278A1 (en) | 2020-09-30 | 2023-08-09 | Guardant Health, Inc. | Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease |
| JP2023547620A (ja) * | 2020-10-23 | 2023-11-13 | ガーダント ヘルス， インコーポレイテッド | 分配および塩基変換を使用してｄｎａを解析するための組成物および方法 |
| EP4251765A1 (en) | 2020-11-30 | 2023-10-04 | Guardant Health, Inc. | Compositions and methods for enriching methylated polynucleotides |
| WO2022140629A1 (en) * | 2020-12-23 | 2022-06-30 | Guardant Health, Inc. | Methods and systems for analyzing methylated polynucleotides |
| EP4271835A1 (en) * | 2020-12-30 | 2023-11-08 | Guardant Health, Inc. | Detection of epigenetic status using sequence-specific degradation |
| WO2022174109A1 (en) | 2021-02-12 | 2022-08-18 | Guardant Health, Inc. | Methods and compositions for detecting nucleic acid variants |
| WO2022204730A1 (en) * | 2021-03-25 | 2022-09-29 | Guardant Health, Inc. | Methods and compositions for quantifying immune cell dna |
| CA3214321A1 (en) * | 2021-04-08 | 2022-10-13 | Nicholas C. Dracopoli | Method of detecting cancer using genome-wide cfdna fragmentation profiles |
| JP2024520422A (ja) | 2021-05-28 | 2024-05-24 | ガーダント ヘルス， インコーポレイテッド | 循環分子をアッセイするための組成物および方法 |
| JP2024523401A (ja) * | 2021-06-21 | 2024-06-28 | ガーダント ヘルス， インコーポレイテッド | コピー数情報に基づく組織起源分析のための方法および組成物 |
| CA3226747A1 (en) * | 2021-07-27 | 2023-02-02 | Chunxiao Song | Compositions and methods related to tet-assisted pyridine borane sequencing for cell-free dna |
| WO2023056065A1 (en) | 2021-09-30 | 2023-04-06 | Guardant Health, Inc. | Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements |
| JP2024540168A (ja) | 2021-11-02 | 2024-10-31 | ガーダント ヘルス， インコーポレイテッド | 品質管理方法 |
| EP4453241A1 (en) | 2021-12-21 | 2024-10-30 | Guardant Health, Inc. | Methods and systems for combinatorial chromatin-ip sequencing |
| WO2023122740A1 (en) | 2021-12-23 | 2023-06-29 | Guardant Health, Inc. | Compositions and methods for detection of metastasis |
| WO2023130101A2 (en) * | 2021-12-30 | 2023-07-06 | AiOnco, Inc. | Methods and probes for separating genomic nucleic acid fractions for cancer risk analysis |
| WO2023197004A1 (en) | 2022-04-07 | 2023-10-12 | Guardant Health, Inc. | Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules |
| JP2025522763A (ja) | 2022-06-30 | 2025-07-17 | ガーダント ヘルス， インコーポレイテッド | 異常にメチル化されたｄｎａの富化 |
| CN119923475A (zh) | 2022-07-21 | 2025-05-02 | 夸登特健康公司 | 用于检测和减少样品制备诱导的甲基化人为假象的方法 |
| EP4587843A1 (en) | 2022-09-16 | 2025-07-23 | Guardant Health, Inc. | Compositions and methods for analyzing soluble proteins |
| EP4594522A2 (en) | 2022-09-27 | 2025-08-06 | Guardant Health, Inc. | Methods for quantifying immune cell dna |
| WO2024138180A2 (en) * | 2022-12-22 | 2024-06-27 | Guardant Health, Inc. | Integrated targeted and whole genome somatic and dna methylation sequencing workflows |
| EP4638781A2 (en) | 2022-12-22 | 2025-10-29 | Guardant Health, Inc. | Methods involving methylation preserving amplification with error correction |
| IT202200027141A1 (it) * | 2022-12-29 | 2024-06-29 | Andrea Crisanti | Metodo per rilevare varianti genetiche minoritarie. |
| WO2024151825A1 (en) | 2023-01-11 | 2024-07-18 | Guardant Health, Inc. | Joint modeling of longitudinal and time-to-event data to predict patient survival |
| WO2024159053A1 (en) | 2023-01-25 | 2024-08-02 | Guardant Health, Inc. | Nucleic acid methylation profiling method |
| CN120898247A (zh) | 2023-04-07 | 2025-11-04 | 夸登特健康公司 | 基于无细胞核酸分子的甲基化状态检测肿瘤的存在 |
| WO2024216112A1 (en) | 2023-04-12 | 2024-10-17 | Guardant Health, Inc. | Promoter methylation detection |
| WO2024229143A1 (en) | 2023-05-01 | 2024-11-07 | Guardant Health, Inc. | Quality control method for enzymatic conversion procedures |
| EP4705508A1 (en) | 2023-05-03 | 2026-03-11 | Guardant Health, Inc. | Methods for analysis of dna methylation |
| WO2024233502A1 (en) | 2023-05-05 | 2024-11-14 | Guardant Health, Inc. | Cell-free dna blood-based test for cancer screening |
| WO2024264065A1 (en) | 2023-06-23 | 2024-12-26 | Guardant Health, Inc. | Methods and compositions for quantifying immune cell nucleic acids |
| WO2025007034A1 (en) | 2023-06-29 | 2025-01-02 | Guardant Health, Inc. | Methods for determining surveillance and therapy for diseases |
| WO2025007038A1 (en) | 2023-06-30 | 2025-01-02 | Guardant Health, Inc. | Methods for early detection of cancer |
| CN121532829A (zh) | 2023-07-14 | 2026-02-13 | 夸登特健康公司 | 使用来自液体活检的dna甲基化对乳腺肿瘤进行分类 |
| CN121569344A (zh) | 2023-07-14 | 2026-02-24 | 夸登特健康公司 | 使用来自液体活检的dna甲基化对结肠直肠肿瘤进行分类 |
| WO2025024497A1 (en) | 2023-07-24 | 2025-01-30 | Guardant Health, Inc. | Significance modeling of clonal-level target variants using methylation detection |
| WO2025029475A1 (en) | 2023-07-28 | 2025-02-06 | Guardant Health, Inc. | Methods to enrich nucleotide variants by negative selection |
| CN121844385A (zh) | 2023-07-28 | 2026-04-10 | 夸登特健康公司 | 用于鉴定变异来源的方法和系统 |
| WO2025029751A1 (en) | 2023-07-31 | 2025-02-06 | Guardant Health, Inc. | Methods and systems for identifying tumor origin |
| WO2025038399A1 (en) | 2023-08-11 | 2025-02-20 | Guardant Health, Inc. | Methylated enrichment methods for single-molecule genetic and epigenetic sequencing |
| WO2025059338A1 (en) | 2023-09-12 | 2025-03-20 | Guardant Health, Inc. | Methods for analyzing nucleic acids using sequence read family size distribution |
| WO2025064706A1 (en) | 2023-09-19 | 2025-03-27 | Guardant Health, Inc. | Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules |
| WO2025064489A1 (en) | 2023-09-20 | 2025-03-27 | Guardant Health, Inc. | Systems and methods for real world evidence database data integration |
| US20250250638A1 (en) | 2023-10-06 | 2025-08-07 | Guardant Health, Inc. | Genomic and methylation biomarkers for prediction of copy number loss / gene deletion |
| WO2025076452A1 (en) | 2023-10-06 | 2025-04-10 | Guardant Health, Inc. | Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules |
| WO2025085784A1 (en) | 2023-10-18 | 2025-04-24 | Guardant Health, Inc. | Genomic and methylation biomarkers for determining patient risk of heart disease and novel genomic and epigenomic drug targets to decrease risk of heart disease and/or improve patient outcome after myocardial infarction or cardiac injury |
| WO2025090954A1 (en) | 2023-10-26 | 2025-05-01 | Guardant Health, Inc. | Methods for detecting nucleic acid variants |
| WO2025090956A1 (en) | 2023-10-26 | 2025-05-01 | Guardant Health, Inc. | Methods for detecting nucleic acid variants using capture probes |
| WO2025106796A1 (en) | 2023-11-15 | 2025-05-22 | Guardant Health, Inc. | Non-small cell lung cancer (nsclc) histology classification using dna methylation data captured from liquid biopsies |
| WO2025106837A1 (en) | 2023-11-15 | 2025-05-22 | Guardant Health, Inc. | Tumor fraction and outcome association in a real-world non-small cell lung cancer (nsclc) cohort using a methylation-based circulating tumor dna (ctdna) assay |
| WO2025106275A1 (en) | 2023-11-15 | 2025-05-22 | Guardant Health, Inc. | Minimum residual disease (mrd) detection in early stage cancer using urine |
| WO2025106263A1 (en) | 2023-11-15 | 2025-05-22 | Guardant Health, Inc. | Joint modeling of longitudinal and time-to-event data to predict patient survival |
| WO2025137620A1 (en) | 2023-12-21 | 2025-06-26 | Guardant Health, Inc. | Methods for high quality and high accuracy methylation sequencing |
| WO2025137389A2 (en) | 2023-12-22 | 2025-06-26 | Guardant Health, Inc. | Methods for targeted single-molecule genetic and epigenetic sequencing |
| WO2025160433A1 (en) | 2024-01-24 | 2025-07-31 | Guardant Health, Inc. | Methods for analyzing sequencing reads |
| WO2025207817A1 (en) | 2024-03-26 | 2025-10-02 | Guardant Health, Inc. | Method of determining the likelihood of a disease by combining biomarkers and imaging |
| WO2025207921A1 (en) | 2024-03-28 | 2025-10-02 | Guardant Health, Inc. | Methods for methylation enrichment using cpg-specific deamination |
| WO2025208044A1 (en) | 2024-03-28 | 2025-10-02 | Guardant Health, Inc. | Methods for cancer detection using molecular patterns |
| WO2025235602A1 (en) | 2024-05-07 | 2025-11-13 | Guardant Health, Inc. | Predictive, prognostic signatures for immuno-oncology using liquid biopsy |
| WO2025235889A1 (en) | 2024-05-10 | 2025-11-13 | Guardant Health, Inc. | Methods involving multiplexed pooled pcr |
| WO2025245433A1 (en) * | 2024-05-23 | 2025-11-27 | Guardant Health, Inc. | Generalized probabilistic generative modeling method for analysis of tumor methylated molecules in target capture regions |
| WO2025250544A1 (en) | 2024-05-31 | 2025-12-04 | Guardant Health, Inc. | Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna |
| WO2026015607A1 (en) | 2024-07-09 | 2026-01-15 | Guardant Health, Inc. | Methods for partitioning hyper-, hypo-, and non-methylated dna |
| WO2026015794A1 (en) | 2024-07-12 | 2026-01-15 | Guardant Health, Inc. | Methods for modifying dna using cpg-specific deamination and uracil base excision |
| WO2026024817A1 (en) | 2024-07-24 | 2026-01-29 | Guardant Health, Inc. | Methods and compositions for anchored multiplex ngs workflows |
| WO2026024956A1 (en) | 2024-07-24 | 2026-01-29 | Guardant Health, Inc. | Selecting low technical noise biomarkers for sensitive molecular diagnostics |
| WO2026024692A1 (en) | 2024-07-24 | 2026-01-29 | Guardant Health, Inc. | Direct methylation single-base resolution sequencing of enriched unmethylated dna |
| WO2026043702A1 (en) | 2024-08-21 | 2026-02-26 | Guardant Health, Inc. | Methods and approaches for personalized identification and monitoring of extrachromosomal circular dna |
| WO2026043718A1 (en) | 2024-08-21 | 2026-02-26 | Guardant Health, Inc. | Methods to monitor patients treated with a cancer vaccine |
| WO2026050179A1 (en) | 2024-08-26 | 2026-03-05 | Guardant Health, Inc. | Tumor fraction (tf) is associated with real-world progression-free survival (rwpfs) in non-small-cell lung cancer (nsclc) patients treated with platinum-based chemotherapy (chemo) |
| WO2026050287A1 (en) | 2024-08-27 | 2026-03-05 | Guardant Health, Inc. | Methylation biomarkers for osimertinib treatment management |
| WO2026060266A1 (en) | 2024-09-13 | 2026-03-19 | Guardant Health, Inc. | Use of copy number variants for the identification of false positive tumor calls |
| WO2026064529A2 (en) | 2024-09-18 | 2026-03-26 | Guardant Health, Inc. | Methods for detecting nucleic acid variants using primers and ligation substrates |
| WO2026073140A1 (en) | 2024-09-27 | 2026-04-02 | Guardant Health, Inc. | Framework to identify genomic regions indicative of one or more biological conditions |
| WO2026076332A1 (en) | 2024-10-03 | 2026-04-09 | Guardant Health, Inc. | Methods involving multi-modal tumor variant identification and tracking of tumor molecules |
| WO2026080838A2 (en) | 2024-10-11 | 2026-04-16 | Guardant Health, Inc. | Methods for detecting nucleic acid variants |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017151524A1 (en) | 2016-02-29 | 2017-09-08 | Foundation Medicine, Inc. | Methods and systems for evaluating tumor mutational burden |
| WO2017190215A1 (en) | 2016-05-03 | 2017-11-09 | University Health Network | Methods of capturing cell-free methylated dna and uses of same |
| WO2018119452A2 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
| US20180305738A1 (en) | 2016-04-14 | 2018-10-25 | Guardant Health, Inc. | Methods of attaching adapters to sample nucleic acids |
Family Cites Families (126)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
| US20030017081A1 (en) | 1994-02-10 | 2003-01-23 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
| DE69528706T2 (de) | 1994-08-19 | 2003-06-12 | Pe Corp. (Ny), Foster City | Gekoppeltes ampflikation- und ligationverfahren |
| US5648245A (en) | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
| AU2324997A (en) | 1996-03-15 | 1997-10-01 | Penn State Research Foundation, The | Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays |
| DE69739909D1 (de) | 1996-03-26 | 2010-07-29 | Michael S Kopreski | Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden |
| GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
| GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
| US6969488B2 (en) | 1998-05-22 | 2005-11-29 | Solexa, Inc. | System and apparatus for sequential processing of analytes |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| JP2002539849A (ja) | 1999-03-26 | 2002-11-26 | ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ | ユニバーサルアレイ |
| EP1169479B1 (en) | 1999-04-09 | 2006-06-28 | EXACT Sciences Corporation | Methods for detecting nucleic acids indicative of cancer |
| EP1046717B1 (en) | 1999-04-20 | 2010-10-06 | National Institute of Advanced Industrial Science and Technology | Method and probes for determining a concentration of target nucleic acid molecules and method for analyzing data obtained by the method |
| US6818395B1 (en) | 1999-06-28 | 2004-11-16 | California Institute Of Technology | Methods and apparatus for analyzing polynucleotide sequences |
| US7501245B2 (en) | 1999-06-28 | 2009-03-10 | Helicos Biosciences Corp. | Methods and apparatuses for analyzing polynucleotide sequences |
| US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
| US6586177B1 (en) | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
| US6849403B1 (en) | 1999-09-08 | 2005-02-01 | Exact Sciences Corporation | Apparatus and method for drug screening |
| AU7537200A (en) | 1999-09-29 | 2001-04-30 | Solexa Ltd. | Polynucleotide sequencing |
| CA2394921A1 (en) | 1999-12-07 | 2001-06-14 | Anthony P. Shuber | Supracolonic aerodigestive neoplasm detection |
| GB2364054B (en) | 2000-03-24 | 2002-05-29 | Smithkline Beecham Corp | Method of amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof |
| EP1158055A1 (fr) | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Méthode pour le diagnostic de cancers |
| ATE377093T1 (de) | 2000-07-07 | 2007-11-15 | Visigen Biotechnologies Inc | Sequenzbestimmung in echtzeit |
| DE60131903T2 (de) | 2000-10-24 | 2008-11-27 | The Board of Trustees of the Leland S. Stanford Junior University, Palo Alto | Direkte multiplex charakterisierung von genomischer dna |
| DE10112515B4 (de) | 2001-03-09 | 2004-02-12 | Epigenomics Ag | Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität |
| WO2003046146A2 (en) | 2001-11-28 | 2003-06-05 | Applera Corporation | Compositions and methods of selective nucleic acid isolation |
| DK1342794T3 (da) | 2002-03-05 | 2006-04-24 | Epigenomics Ag | Fremgangsmåde og anordning til at bestemme vævsspecificitet af fritflydende DNA i legemsvæsker |
| US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US7635564B2 (en) | 2002-10-25 | 2009-12-22 | Agilent Technologies, Inc. | Biopolymeric arrays having replicate elements |
| US10229244B2 (en) | 2002-11-11 | 2019-03-12 | Affymetrix, Inc. | Methods for identifying DNA copy number changes using hidden markov model based estimations |
| ATE443765T1 (de) | 2003-03-21 | 2009-10-15 | Santaris Pharma As | Analoga kurzer interferierender rna (sirna) |
| US8048627B2 (en) | 2003-07-05 | 2011-11-01 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
| ATE435301T1 (de) | 2003-10-16 | 2009-07-15 | Sequenom Inc | Nicht invasiver nachweis fötaler genetischer merkmale |
| DE10348407A1 (de) | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
| US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
| US20100216153A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
| US7937225B2 (en) | 2004-09-03 | 2011-05-03 | New York University | Systems, methods and software arrangements for detection of genome copy number variation |
| CA2579150C (en) | 2004-09-17 | 2014-11-25 | Pacific Biosciences Of California, Inc. | Apparatus and method for analysis of molecules |
| US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
| US20060073506A1 (en) | 2004-09-17 | 2006-04-06 | Affymetrix, Inc. | Methods for identifying biological samples |
| US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
| US7424371B2 (en) | 2004-12-21 | 2008-09-09 | Helicos Biosciences Corporation | Nucleic acid analysis |
| US7482120B2 (en) | 2005-01-28 | 2009-01-27 | Helicos Biosciences Corporation | Methods and compositions for improving fidelity in a nucleic acid synthesis reaction |
| US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
| ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
| EP1712639B1 (en) | 2005-04-06 | 2008-08-27 | Maurice Stroun | Method for the diagnosis of cancer by detecting circulating DNA and RNA |
| US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
| WO2007037678A2 (en) | 2005-09-29 | 2007-04-05 | Keygene N.V. | High throughput screening of mutagenized populations |
| WO2007087312A2 (en) | 2006-01-23 | 2007-08-02 | Population Genetics Technologies Ltd. | Molecular counting |
| US7282337B1 (en) | 2006-04-14 | 2007-10-16 | Helicos Biosciences Corporation | Methods for increasing accuracy of nucleic acid sequencing |
| US8383338B2 (en) | 2006-04-24 | 2013-02-26 | Roche Nimblegen, Inc. | Methods and systems for uniform enrichment of genomic regions |
| CN103424541B (zh) | 2006-05-18 | 2018-01-30 | 分子压型学会股份有限公司 | 确定针对病状的个性化医疗介入的系统和方法 |
| US20080090239A1 (en) | 2006-06-14 | 2008-04-17 | Daniel Shoemaker | Rare cell analysis using sample splitting and dna tags |
| CA2669728C (en) | 2006-11-15 | 2017-04-11 | Biospherex Llc | Multitag sequencing and ecogenomics analysis |
| US20080131887A1 (en) | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
| WO2008148072A2 (en) | 2007-05-24 | 2008-12-04 | The Brigham And Women's Hospital, Inc. | Disease-associated genetic variations and methods for obtaining and using same |
| JP2010528608A (ja) | 2007-06-01 | 2010-08-26 | ４５４ ライフ サイエンシーズ コーポレイション | 複合的な混合物から個々の試料を特定するためのシステムおよび方法 |
| PL2557520T3 (pl) | 2007-07-23 | 2021-10-11 | The Chinese University Of Hong Kong | Określanie zaburzenia równowagi sekwencji kwasu nukleinowego |
| JP2011508450A (ja) | 2007-12-28 | 2011-03-10 | スリーエム イノベイティブ プロパティズ カンパニー | 均一な波長の発光を伴う下方変換された光源 |
| EP2245198A1 (en) | 2008-02-04 | 2010-11-03 | Massachusetts Institute of Technology | Selection of nucleic acids by solution hybridization to oligonucleotide baits |
| JP2011511644A (ja) | 2008-02-12 | 2011-04-14 | ノバルティス アーゲー | 無細胞のアポトーシス性核酸または胎児核酸を単離するための方法 |
| EP4230747A3 (en) | 2008-03-28 | 2023-11-15 | Pacific Biosciences Of California, Inc. | Compositions and methods for nucleic acid sequencing |
| US20090318305A1 (en) | 2008-06-18 | 2009-12-24 | Xi Erick Lin | Methods for selectively capturing and amplifying exons or targeted genomic regions from biological samples |
| US20100069250A1 (en) | 2008-08-16 | 2010-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Digital PCR Calibration for High Throughput Sequencing |
| US8383345B2 (en) | 2008-09-12 | 2013-02-26 | University Of Washington | Sequence tag directed subassembly of short sequencing reads into long sequencing reads |
| US20100323348A1 (en) | 2009-01-31 | 2010-12-23 | The Regents Of The University Of Colorado, A Body Corporate | Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process |
| WO2011063210A2 (en) | 2009-11-20 | 2011-05-26 | Life Technologies Corporation | Methods of mapping genomic methylation patterns |
| US8835358B2 (en) | 2009-12-15 | 2014-09-16 | Cellular Research, Inc. | Digital counting of individual molecules by stochastic attachment of diverse labels |
| EP2513341B1 (en) | 2010-01-19 | 2017-04-12 | Verinata Health, Inc | Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing |
| EP2370599B1 (en) | 2010-01-19 | 2015-01-21 | Verinata Health, Inc | Method for determining copy number variations |
| EP2591433A4 (en) | 2010-07-06 | 2017-05-17 | Life Technologies Corporation | Systems and methods to detect copy number variation |
| US9079155B2 (en) | 2010-07-29 | 2015-07-14 | Toto Ltd. | Photocatalyst coated body and photocatalyst coating liquid |
| ES2523140T3 (es) | 2010-09-21 | 2014-11-21 | Population Genetics Technologies Ltd. | Aumento de la confianza en las identificaciones de alelos con el recuento molecular |
| US8725422B2 (en) | 2010-10-13 | 2014-05-13 | Complete Genomics, Inc. | Methods for estimating genome-wide copy number variations |
| CA3210003A1 (en) | 2010-10-22 | 2012-04-26 | Cold Spring Harbor Laboratory | Varietal counting of nucleic acids for obtaining genomic copy number information |
| KR102759126B1 (ko) | 2010-12-30 | 2025-01-24 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
| WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
| ES2986436T3 (es) | 2011-04-15 | 2024-11-11 | Univ Johns Hopkins | Sistema de secuenciación segura |
| EP3395957B1 (en) | 2011-04-25 | 2020-08-12 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
| SG10201605049QA (en) | 2011-05-20 | 2016-07-28 | Fluidigm Corp | Nucleic acid encoding reactions |
| KR101454886B1 (ko) | 2011-08-01 | 2014-11-03 | 주식회사 셀레믹스 | 핵산분자의 제조방법 |
| EP2768985B1 (en) | 2011-10-21 | 2019-03-20 | Chronix Biomedical | Colorectal cancer associated circulating nucleic acid biomarkers |
| WO2013060762A1 (en) | 2011-10-25 | 2013-05-02 | Roche Diagnostics Gmbh | Method for diagnosing a disease based on plasma-dna distribution |
| JP6224689B2 (ja) | 2012-03-15 | 2017-11-01 | ニユー・イングランド・バイオレイブス・インコーポレイテツド | シトシンとこれの修飾物とを識別するための、およびメチローム分析のための方法および組成物 |
| US20140066317A1 (en) | 2012-09-04 | 2014-03-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| US20160040229A1 (en) | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
| CN104781421B (zh) | 2012-09-04 | 2020-06-05 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| US20140287408A1 (en) | 2013-03-13 | 2014-09-25 | Abbott Molecular Inc. | Target sequence enrichment |
| CN114574581A (zh) | 2013-03-15 | 2022-06-03 | 夸登特健康公司 | 检测稀有突变和拷贝数变异的系统和方法 |
| WO2014151117A1 (en) | 2013-03-15 | 2014-09-25 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
| SG11201508985VA (en) | 2013-05-23 | 2015-12-30 | Univ Leland Stanford Junior | Transposition into native chromatin for personal epigenomics |
| ES2660989T3 (es) | 2013-12-28 | 2018-03-27 | Guardant Health, Inc. | Métodos y sistemas para detectar variantes genéticas |
| ES2844229T3 (es) | 2014-05-13 | 2021-07-21 | Univ Texas | Mutaciones génicas y alteraciones en el número de copias de EGFR, KRAS y MET |
| CN105296606B (zh) | 2014-07-25 | 2019-08-09 | 深圳华大基因股份有限公司 | 确定生物样本中游离核酸比例的方法、装置及其用途 |
| EP4358097A1 (en) | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
| US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
| CN107075730A (zh) | 2014-09-12 | 2017-08-18 | 利兰·斯坦福青年大学托管委员会 | 循环核酸的鉴定及用途 |
| EP3766986B1 (en) | 2014-12-31 | 2022-06-01 | Guardant Health, Inc. | Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results |
| HUE058263T2 (hu) | 2015-02-10 | 2022-07-28 | Univ Hong Kong Chinese | Mutációk detektálása rákszûrési és magzatelemzési célból |
| US20160281166A1 (en) | 2015-03-23 | 2016-09-29 | Parabase Genomics, Inc. | Methods and systems for screening diseases in subjects |
| EP3288455B1 (en) | 2015-05-01 | 2023-12-06 | Guardant Health, Inc. | Diagnostic methods |
| CN108138230B (zh) | 2015-07-21 | 2023-03-10 | 夸登特健康公司 | 用于捕获融合基因的锁核酸 |
| IL305462A (en) | 2015-07-23 | 2023-10-01 | Univ Hong Kong Chinese | DNA fragmentation pattern analysis suitable clean |
| US12540351B2 (en) | 2015-09-02 | 2026-02-03 | Guardant Health, Inc. | Identification of somatic mutations versus germline variants for cell-free DNA variant calling applications |
| US11302416B2 (en) | 2015-09-02 | 2022-04-12 | Guardant Health | Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications |
| JP6991134B2 (ja) | 2015-10-09 | 2022-01-12 | ガーダント ヘルス， インコーポレイテッド | 無細胞ｄｎａを使用する集団ベースの処置レコメンダ |
| WO2017062970A1 (en) | 2015-10-10 | 2017-04-13 | Guardant Health, Inc. | Methods and applications of gene fusion detection in cell-free dna analysis |
| SG11201805119QA (en) | 2015-12-17 | 2018-07-30 | Guardant Health Inc | Methods to determine tumor gene copy number by analysis of cell-free dna |
| CN116640847A (zh) | 2016-02-02 | 2023-08-25 | 夸登特健康公司 | 癌症进化检测和诊断 |
| WO2017176630A1 (en) | 2016-04-07 | 2017-10-12 | The Board Of Trustees Of The Leland Stanford Junior University | Noninvasive diagnostics by sequencing 5-hydroxymethylated cell-free dna |
| ES3002715T3 (en) * | 2016-04-14 | 2025-03-07 | Guardant Health Inc | Methods for early detection of cancer |
| US10144962B2 (en) * | 2016-06-30 | 2018-12-04 | Grail, Inc. | Differential tagging of RNA for preparation of a cell-free DNA/RNA sequencing library |
| WO2018009723A1 (en) | 2016-07-06 | 2018-01-11 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
| US11566284B2 (en) | 2016-08-10 | 2023-01-31 | Grail, Llc | Methods of preparing dual-indexed DNA libraries for bisulfite conversion sequencing |
| US9850523B1 (en) | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| EP3461274B1 (en) | 2016-09-30 | 2020-11-04 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
| US11993811B2 (en) * | 2017-01-31 | 2024-05-28 | Myriad Women's Health, Inc. | Systems and methods for identifying and quantifying gene copy number variations |
| JP2020527340A (ja) | 2017-06-30 | 2020-09-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | セルフリーｄｎａ中のｄｎａメチル化を評価するための方法およびシステム |
| NZ765943A (en) | 2018-01-08 | 2022-10-28 | Ludwig Inst For Cancer Res Ltd | Bisulfite-free, base-resolution identification of cytosine modifications |
| BR112020024727A2 (pt) | 2018-06-11 | 2021-03-23 | Foundation Medicine, Inc. | composições e métodos para avaliação de alterações genômicas |
| WO2020023420A2 (en) * | 2018-07-23 | 2020-01-30 | Guardant Health, Inc. | Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage |
| WO2020160414A1 (en) * | 2019-01-31 | 2020-08-06 | Guardant Health, Inc. | Compositions and methods for isolating cell-free dna |
| EP3976822A1 (en) * | 2019-05-31 | 2022-04-06 | Guardant Health, Inc. | Methods and systems for improving patient monitoring after surgery |
| US11891653B2 (en) * | 2019-09-30 | 2024-02-06 | Guardant Health, Inc. | Compositions and methods for analyzing cell-free DNA in methylation partitioning assays |
| EP4617375A3 (en) * | 2019-11-26 | 2025-10-29 | Guardant Health, Inc. | Methods, compositions and systems for improving the binding of methylated polynucleotides |
-
2020
- 2020-01-31 WO PCT/US2020/016120 patent/WO2020160414A1/en not_active Ceased
- 2020-01-31 EP EP25151855.1A patent/EP4567131A3/en active Pending
- 2020-01-31 US US16/778,572 patent/US11643693B2/en active Active
- 2020-01-31 AU AU2020216438A patent/AU2020216438A1/en not_active Abandoned
- 2020-01-31 EP EP20708962.4A patent/EP3918089B1/en active Active
- 2020-01-31 JP JP2021544183A patent/JP7573536B2/ja active Active
- 2020-01-31 CN CN202080026244.0A patent/CN113661249B/zh active Active
- 2020-01-31 ES ES20708962T patent/ES3013495T3/es active Active
- 2020-01-31 CA CA3126428A patent/CA3126428A1/en active Pending
-
2023
- 2023-05-08 US US18/314,056 patent/US20230323474A1/en active Pending
-
2024
- 2024-06-28 JP JP2024104756A patent/JP2024125391A/ja active Pending
-
2026
- 2026-04-07 AU AU2026202605A patent/AU2026202605A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017151524A1 (en) | 2016-02-29 | 2017-09-08 | Foundation Medicine, Inc. | Methods and systems for evaluating tumor mutational burden |
| US20180305738A1 (en) | 2016-04-14 | 2018-10-25 | Guardant Health, Inc. | Methods of attaching adapters to sample nucleic acids |
| WO2017190215A1 (en) | 2016-05-03 | 2017-11-09 | University Health Network | Methods of capturing cell-free methylated dna and uses of same |
| WO2018119452A2 (en) | 2016-12-22 | 2018-06-28 | Guardant Health, Inc. | Methods and systems for analyzing nucleic acid molecules |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020216438A1 (en) | 2021-07-29 |
| EP3918089A1 (en) | 2021-12-08 |
| AU2026202605A1 (en) | 2026-04-23 |
| EP3918089B1 (en) | 2025-01-15 |
| JP2022519045A (ja) | 2022-03-18 |
| US20230323474A1 (en) | 2023-10-12 |
| EP3918089C0 (en) | 2025-01-15 |
| ES3013495T3 (en) | 2025-04-14 |
| WO2020160414A1 (en) | 2020-08-06 |
| CA3126428A1 (en) | 2020-08-06 |
| EP4567131A2 (en) | 2025-06-11 |
| CN113661249A (zh) | 2021-11-16 |
| JP2024125391A (ja) | 2024-09-18 |
| EP4567131A3 (en) | 2025-09-03 |
| CN113661249B (zh) | 2025-07-01 |
| US11643693B2 (en) | 2023-05-09 |
| US20200248272A1 (en) | 2020-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7573536B2 (ja) | 無細胞ｄｎａを単離するための組成物および方法 | |
| JP7717057B2 (ja) | メチル化分配アッセイにおいて無細胞ｄｎａを解析するための組成物および方法 | |
| ES3018032T3 (en) | Methods for isolating cell-free dna | |
| EP3976822A1 (en) | Methods and systems for improving patient monitoring after surgery | |
| JP2023551292A (ja) | メチル化されたポリヌクレオチドを富化するための組成物および方法 | |
| EP4041888A1 (en) | Use of cell free bacterial nucleic acids for detection of cancer | |
| WO2023282916A1 (en) | Methods of detecting genomic rearrangements using cell free nucleic acids | |
| JP2026035733A (ja) | メチル化ポリヌクレオチドの結合を改善するための方法、組成物およびシステム | |
| JP2024056984A (ja) | エピジェネティック区画アッセイを較正するための方法、組成物およびシステム | |
| EP4291679A1 (en) | Methods and compositions for detecting nucleic acid variants | |
| US20230313288A1 (en) | Methods for sequence determination using partitioned nucleic acids | |
| EP4179111B1 (en) | Methods of detecting genomic rearrangements using cell free nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230131 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230131 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20231228 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240327 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20240527 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240628 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240917 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241015 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7573536 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |